2Traynor AE, Schroeder J, Rosa RM, et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet,2000, 356: 701-707. 被引量：1
1Ikchara S.Bone marrow transplantation for autoimmune disease.Acta Haematol,1998,99:116-132. 被引量：1
2Euler HH,Marmont AM,Bacigalupo A,et al.Early recurrence or persistence of amoimmune diseases after unmanipulated autologous stem cell transplantation.Blood,1996,88:3621-3625. 被引量：1
3Kushida T,Inaba M,Hisha H,et al.Intra-bone marrow injection of allogeneic bone marrow cells:a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice.Blood,2001,97:3292-3299. 被引量：1
4Nakamura K,Amakawa R,Takebayashi M,et al.IL-4-producing CD8 (+) T cells may be an immunological hallmark of chronic GVHD.Bone Marrow Transplant,2005,36:639-647. 被引量：1
5Mosmann TR,Cherwinski It,Bond MW,et al.Two types of murine helper T cell clone (Ⅰ):definition according to profiles of lymphokine activities and secreted proteins.J Immunol,1986,136:2348-2357. 被引量：1
6Pittenger MF,Mackay AM,Beck SC,et al.Multilineage potential of adult human mesenchymal stem cells.Science,1999; 284:143-147. 被引量：1
8Le Blanc K,Tammik L,Sundberg B,et al.Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex.Scand J Immunol,2003,57:11-20. 被引量：1
9Bartholomew A,Sturgeon C,Siatskas M,et al.Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.Exp Hematol,2002,30:42-48. 被引量：1
10Le Blanc K,Rasmusson I,Sundberg B,et al.Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.Lancet,2004,363:1439-1441. 被引量：1
